1. The Pill Won’t Do All the Work for You
When Kris R. started taking semaglutide (Wegovy), an oral GLP-1, in March 2026, she thought the weight would simply melt off. “I thought it was a miracle pill, and that it did the work,” Kris says. “But it kind of just helps you do the work.”
For Nusha Nouhi, PhD, a clinical psychologist based in San Diego, both the oral and injectable GLP-1s have helped quiet the “food noise,” but neither treatment has changed her relationship with food.
Nouhi began using GLP-1 medications in 2021, starting with the daily injectable liraglutide (Saxenda), then moving to the weekly injectable Wegovy and weekly injectable tirzepatide (Zepbound). She switched to daily oral semaglutide in March 2026. She has lost about 50 lb over her five-year GLP-1 journey, which included taking some time off the treatment.
C. Herrera, a Florida-based medical professional, took weekly injectable semaglutide (Ozempic) for about two years before switching to daily oral semaglutide. Neither treatment, she’s found, has replaced the need to make healthy lifestyle choices. She still has to plan meals, make thoughtful food choices, and stay active, even when fatigue and other health concerns make that more challenging.
2. You May Not Want to Take a Pill in the Morning
For some people, that’s no big deal. For others, it’s a logistical hurdle.
Kris, for instance, isn’t bothered by the 30-minute wait. “You could wake up, take it first thing, take your shower, get dressed, and those 30 minutes are up,” she says. But she recognizes that the routine might feel different for someone racing to work or trying to take several morning medications in the correct order.
That’s the case for Herrera, who sometimes struggles to take the pill — and accommodate the 30-minute wait time — in the morning rush to eat breakfast and get out the door.
3. You Might Have Different Results on an Oral GLP-1
Both Nouhi and Herrera say the oral GLP-1s are more convenient, but they also believe they lost more weight on the injectables.
Nouhi, for instance, travels frequently, and carrying a bottle of tablets is easier than traveling with injection pens. She now takes the maximum 25 milligrams (mg) dose of the Wegovy pill. Despite the convenience, she still thinks her body responded best to Zepbound, an injectable.
Herrera also believes the Wegovy pill has produced less weight loss and taken longer to work than Ozempic, an injection. Even so, she continues taking the tablet because it has been easier for her to tolerate.
These experiences don’t mean injections are always more effective for everyone — rather, that switching from an injection to a tablet, even when the medications contain the same active ingredient, might produce different results.
